RB
Regencell Bioscience Holdings Ltd
🇺🇸XNAS.RGCUnited StatesHealthcare
$5.69USDdown -0.05 (-0.87%)OpenEnd of day6:09 PM
Price$5.69-0.05 (-0.87%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- KYG7487R1002
- CUSIP
- Not reported
Company
- Employees
- 10
- Headquarters
- Causeway Bay, United States
- CEO
- Mr. Yat-Gai Au
Market
- Shares outstanding
- 494.5M
- Market cap
- $2.81B
Key dates
- Next earnings
- Oct 30, 2026
Highlights
- Market cap
- $2.81B
- EPS LTM
- -$0.01
- P/E LTM
- -23.10
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- Not reported
- Net income
- -$2.78M-5.07%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$3.54M-19.72%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.